LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi
6th May 2026 09:28
(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More
| Price | 47.30p on 13-05-2026 at 07:58:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 47.70p |
| Sell | 46.80p |
| Last Trade: | Buy 20,000.00 at 47.511p |
| Day's Volume: | 70,191 |
| Last Close: | 47.30p |
| Open: | 47.30p |
| ISIN: | GB00BF044593 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 46.00p - 72.80p |
| Market Capitalisation: | £188.31m |
| VWAP: | 47.51204p |
| Shares in Issue: | 398.11m |
CLS Holdings (CLI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 20,000 | 47.511p | Ordinary |
08:58:11 - 13-May-26 |
| Buy* | 10,000 | 47.511p | Ordinary |
08:53:13 - 13-May-26 |
| Buy* | 10,000 | 47.511p | Ordinary |
08:52:39 - 13-May-26 |
| Buy* | 10,000 | 47.511p | Ordinary |
08:52:00 - 13-May-26 |
| Buy* | 10,000 | 47.511p | Ordinary |
08:50:50 - 13-May-26 |
| Buy* | 20 | 47.529p | Ordinary |
08:32:45 - 13-May-26 |
| Buy* | 10,000 | 47.5005p | Ordinary |
08:24:11 - 13-May-26 |
| Buy* | 15 | 47.52p | Ordinary |
08:16:51 - 13-May-26 |
| Buy* | 3 | 48.65p | SI Trade |
08:03:29 - 13-May-26 |
| Buy* | 153 | 48.65p | SI Trade |
08:03:29 - 13-May-26 |
CLS Holdings (CLI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Apr 2026 1:05 pm | RNS | Director/PDMR Shareholding |
| 29th Apr 2026 2:12 pm | RNS | Director/PDMR Shareholding |
| 27th Apr 2026 7:00 am | RNS | CLS announces sale of The Brix, Essen |
| 23rd Apr 2026 4:00 pm | RNS | Result of AGM |
| 16th Apr 2026 2:59 pm | RNS | Scrip Dividend Reference Share Price |
| 15th Apr 2026 12:32 pm | RNS | Director/PDMR Shareholding |
| 9th Apr 2026 3:07 pm | RNS | TR-1: Notification of major holdings |
| 25th Mar 2026 9:58 am | RNS | TR-1: Notification of major holdings |
| 23rd Mar 2026 4:05 pm | RNS | Publication of 2025 Annual Report & Notice of AGM |
| 16th Mar 2026 5:46 pm | RNS | Director/PDMR Shareholding |